Delivery Order SPE2DB22D2206-SPE2DB24FDR19
- Not listed
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LORBRENA 100 MG TABLET 30S. The $21,930.68 contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a range of medical commodities to support military treatment programs...
- The Defense Logistics Agency awarded a delivery order valued at $24.5K to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Lorbrena 100 mg tablets (30-count units). The contract, which is not set-aside, features firm fixed-price pricing and is scheduled for completion by February 10, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of Cencora, Inc. and serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $24.5K to AmerisourceBergen Drug Corp for the supply of Lorbrena 25 mg tablets (30-count units) on January 8, 2026, with completion scheduled for January 30, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded a delivery order valued at $12.25K to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units), with performance completion scheduled for December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- On January 29, 2026, the Defense Logistics Agency awarded a delivery order valued at $12.3K to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of February 20, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the parent entity Cencora, Inc., which does business as...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,543.70 firm fixed-price delivery order is for the supply of LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product, with a performance period through July 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award, valued at $12,365.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Lynparza 150 mg tablets, a specialty oncology medication. The fixed-price delivery order is valued at $9,572.69 and has a completion date of November 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $59,015.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award, valued at $18,843.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FDR19Delivery Order
This federal contract award, with a ceiling value of $21,156.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, covering critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The specific award is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of October 31, 2023. This contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 10/10/23 |